SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(SVENNINGSSON I. B.)
 

Search: WFRF:(SVENNINGSSON I. B.) > Multi-cohort profil...

Multi-cohort profiling reveals elevated CSF levels of brain-enriched proteins in Alzheimer's disease

Bergström, Sofia (author)
KTH,Science for Life Laboratory, SciLifeLab,Affinitets-proteomik,Division of Affinity Proteomics Department of Protein Science SciLifeLab KTH Royal Institute of Technology Stockholm Sweden
Remnestål, Julia (author)
KTH,Affinitets-proteomik,Science for Life Laboratory, SciLifeLab,Division of Affinity Proteomics Department of Protein Science SciLifeLab KTH Royal Institute of Technology Stockholm Sweden
Yousef, Jamil (author)
KTH,Affinitets-proteomik,Science for Life Laboratory, SciLifeLab,Division of Affinity Proteomics Department of Protein Science SciLifeLab KTH Royal Institute of Technology Stockholm Sweden
show more...
Olofsson, Jennie (author)
KTH,Science for Life Laboratory, SciLifeLab,Affinitets-proteomik,Division of Affinity Proteomics Department of Protein Science SciLifeLab KTH Royal Institute of Technology Stockholm Sweden
Markaki, I. (author)
Karolinska Institutet,Department of Clinical Neuroscience Karolinska Institutet Stockholm Sweden
Carvalho, S. (author)
Sorbonne Université Institut du Cerveau ‐ Paris Brain Institute ‐ ICM, Assistance‐Publique Hôpitaux de Paris INSERM CNRS Hôpital Pitié‐Salpêtrière Department of Neurology Centre d’Investigation Clinique Neurosciences Paris France
Corvol, J. C. (author)
Sorbonne Université Institut du Cerveau ‐ Paris Brain Institute ‐ ICM, Assistance‐Publique Hôpitaux de Paris INSERM CNRS Hôpital Pitié‐Salpêtrière Department of Neurology Centre d’Investigation Clinique Neurosciences Paris France
Kultima, Kim (author)
Uppsala universitet,Klinisk kemi,Institutionen för farmaceutisk biovetenskap,Cancerfarmakologi och beräkningsmedicin
Kilander, Lena (author)
Uppsala universitet,Geriatrik
Löwenmark, Malin, 1969- (author)
Uppsala universitet,Geriatrik
Ingelsson, Martin (author)
Uppsala universitet,Geriatrik
Blennow, Kaj, 1958 (author)
Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi,Institute of Neuroscience and Physiology,Department of Psychiatry and Neurochemistry Institute of Neuroscience and Physiology The Sahlgrenska Academy University of Gothenburg;Clinical Neurochemistry Laboratory Sahlgrenska University Hospital Mölndal Sweden
Zetterberg, Henrik, 1973 (author)
Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi,Institute of Neuroscience and Physiology,Department of Psychiatry and Neurochemistry Institute of Neuroscience and Physiology The Sahlgrenska Academy University of Gothenburg;Clinical Neurochemistry Laboratory Sahlgrenska University Hospital Mölndal Sweden;Department of Neurodegenerative Disease UCL Institute of Neurology London UK;UK Dementia Research Institute at UCL London UK
Nellgård, Bengt, 1956 (author)
Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för anestesiologi och intensivvård,Institute of Clinical Sciences, Department of Anesthesiology and Intensive care,Anesthesiology and Intensive Care Medicine Sahlgrenska University Hospital Mölndal Sweden;Department of Anesthesiology and Intensive Care Medicine Institute of Clinical Sciences The Sahlgrenska Academy University of Gothenburg
Brosseron, F. (author)
Universitätsklinikum Bonn Germany;German Center for Neurodegenerative Diseases (DZNE) Bonn Germany
Heneka, M. T. (author)
Universitätsklinikum Bonn Germany
Bosch, B. (author)
Alzheimer’s and other cognitive disorders Unit. Service of Neurology Hospital Clínic de Barcelona Institut d'Investigació Biomèdica August Pi i Sunyer University of Barcelona Barcelona Spain
Sanchez-Valle, R. (author)
Alzheimer’s and other cognitive disorders Unit. Service of Neurology Hospital Clínic de Barcelona Institut d'Investigació Biomèdica August Pi i Sunyer University of Barcelona Barcelona Spain
Månberg, Anna, 1985- (author)
KTH,Science for Life Laboratory, SciLifeLab,Affinitets-proteomik,Division of Affinity Proteomics Department of Protein Science SciLifeLab KTH Royal Institute of Technology Stockholm Sweden
Svenningsson, P. (author)
Karolinska Institutet,Department of Clinical Neuroscience Karolinska Institutet Stockholm Sweden
Nilsson, Peter (author)
KTH,Science for Life Laboratory, SciLifeLab,Affinitets-proteomik,Division of Affinity Proteomics Department of Protein Science SciLifeLab KTH Royal Institute of Technology Stockholm Sweden
show less...
 (creator_code:org_t)
2021-06-15
2021
English.
In: Annals of Clinical and Translational Neurology. - : Wiley. - 2328-9503. ; 8:7, s. 1456-1470
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Objective: Decreased amyloid beta (A beta) 42 together with increased tau and phospho-tau in cerebrospinal fluid (CSF) is indicative of Alzheimer's disease (AD). However, the molecular pathophysiology underlying the slowly progressive cognitive decline observed in AD is not fully understood and it is not known what other CSF biomarkers may be altered in early disease stages. Methods: We utilized an antibody-based suspension bead array to analyze levels of 216 proteins in CSF from AD patients, patients with mild cognitive impairment (MCI), and controls from two independent cohorts collected within the AETIONOMY consortium. Two additional cohorts from Sweden were used for biological verification. Results: Six proteins, amphiphysin (AMPH), aquaporin 4 (AQP4), cAMP-regulated phosphoprotein 21 (ARPP21), growth-associated protein 43 (GAP43), neurofilament medium polypeptide (NEFM), and synuclein beta (SNCB) were found at increased levels in CSF from AD patients compared with controls. Next, we used CSF levels of A beta 42 and tau for the stratification of the MCI patients and observed increased levels of AMPH, AQP4, ARPP21, GAP43, and SNCB in the MCI subgroups with abnormal tau levels compared with controls. Further characterization revealed strong to moderate correlations between these five proteins and tau concentrations. Interpretation: In conclusion, we report six extensively replicated candidate biomarkers with the potential to reflect disease development. Continued evaluation of these proteins will determine to what extent they can aid in the discrimination of MCI patients with and without an underlying AD etiology, and if they have the potential to contribute to a better understanding of the AD continuum.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Neurovetenskaper (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Neurosciences (hsv//eng)

Keyword

serum neurofilament light
mild cognitive impairment
cerebrospinal-fluid
plasma biomarkers
pathology
neurodegeneration
amphiphysin
association
determinant
proteomics
Neurosciences & Neurology
Alzheimers disease
Bioteknologi

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view